Compare DNA & FPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DNA | FPF |
|---|---|---|
| Founded | 2008 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 835.7M | 946.2M |
| IPO Year | 2020 | 2013 |
| Metric | DNA | FPF |
|---|---|---|
| Price | $11.35 | $15.83 |
| Analyst Decision | Sell | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 2.6M | 349.1K |
| Earning Date | 11-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.08% |
| EPS Growth | ★ 46.49 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $170,155,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.05 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.37 | $15.11 |
| 52 Week High | $18.22 | $19.36 |
| Indicator | DNA | FPF |
|---|---|---|
| Relative Strength Index (RSI) | 51.79 | 48.24 |
| Support Level | $6.75 | $15.21 |
| Resistance Level | $13.97 | $15.99 |
| Average True Range (ATR) | 1.26 | 0.25 |
| MACD | -0.11 | 0.06 |
| Stochastic Oscillator | 41.15 | 83.33 |
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
First Trust Inter Dur Pref& Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek a high level of current income. Further, it has a secondary objective of capital appreciation. The Fund invests in the traditional preferred securities, hybrid preferred securities, floating rate & fixed-to-floating rate preferred securities, debt securities, convertible securities, and contingent convertible securities issued by U.S. and non-U.S. companies. Its investment portfolio includes industries such as Banks, Insurance, Capital Markets, Electric Utilities, Oil, Gas & Consumable Fuels, Food Products, and others.